Position in KALV
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$10,380,034
+$4,372,349 QoQ
Shares Held
515,650
+38.6% QoQ
Ownership
0.969%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#31
of 182 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 99.9833220207505.ToString("F0")%
Shared 0.ToString("F0")%
None 0.016677979249490934.ToString("F0")%
Common Shares in KALV Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026UBS Group AG holds $8,307,109,707 across 562 Biotechnology names. KALV ranks #101 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
22,619,472 | $626,559,372 | |
| 2 | PTGX |
Protagonist Therapeutics, Inc
|
5,177,796 | $545,739,697 | |
| 3 | ABVX |
Abivax S.A.
|
4,547,406 | $506,353,656 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
4,386,791 | $426,615,424 | |
| 5 | INSM |
INSMED Inc
|
1,737,481 | $284,112,890 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
630,618 | $281,596,158 | |
| 7 | APLS |
Apellis Pharmaceuticals, Inc.
|
6,206,681 | $249,694,775 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
299,979 | $231,775,770 |
All Filings in KALV
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $10,380,034 | 515,650 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $6,007,685 | 371,993 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $5,531,521 | 454,148 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $3,084,693 | 272,861 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $5,858,891 | 507,703 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $3,173,124 | 374,631 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $502,906 | 43,429 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $157,921 | 13,406 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $338,211 | 28,517 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $332,023 | 27,104 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $214,421 | 22,266 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $142,821 | 15,869 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $53,023 | 6,746 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $65,125 | 9,634 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $17,876 | 1,232 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $10,469 | 1,064 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $633,716 | 42,993 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $708,637 | 53,563 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $579,828 | 33,228 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $103,555 | 4,322 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $276,835 | 10,776 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $33,593 | 1,769 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $9,543 | 758 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $52,211 | 4,315 | Shares | Sole | 2020-07-31 | |
| 2020-03-31 | $57,459 | 7,511 | Shares | Sole | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||